Immunohistochemical analysis of 17β-hydroxysteroid dehydrogenase isozymes in human ovarian surface epithelium and epithelial ovarian carcinoma.
Epidemiological studies have indicated a relationship between gonadal steroid hormones, primarily estrogens, and epithelial ovarian carcinoma. In situ estrogen metabolism and synthesis have been considered to play important roles in the development of the progression of epithelial ovarian carcinoma. 17β-Hydroxysteroid dehydrogenases (17β-HSDs) are a group of intracellular isozymes catalyzing interconversions between estradiol (E2) and estrone (E1). In the last step of steroidogenesis, 17β-HSD type 1 catalyzes the 17β-reduction and produces E2 from E1. The oxidative enzymes known as types 2, 4, and 8 are potent estrogen-inactivating enzymes that convert E2 to E1. Here we report the immunoexpression of 17β-HSD types 1, 2, 4, and 8 in normal human ovarian surface epithelium (OSE) and epithelial ovarian carcinoma. For this study, novel polyclonal antibodies were generated against each type of 17β-HSD. Of the six normal OSE cases investigated, 17β-HSD types 1, 4, and 8, but not type 2, were found in the cytoplasm of epithelial cells. In 58 cases of epithelial ovarian carcinoma (45 serous, 4 endometrioid, 4 mucinous, and 5 clear cell), estrogen-inactivating 17β-HSDs were commonly found (type 2, 84.5%; type 4, 82.8%; type 8, 86.2%), whereas type 1 was detected in only 10 cases (17.2%). These results indicate that 17β-HSDs may be involved in the protective and/or suppressive effects against the estrogen-dependent proliferation of epithelial ovarian carcinoma.
Department of Gynecology, and Reproductive Medicine and Surgery, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan.
Ken-ichi
K
Motohara
Hironori
H
Tashiro
Yumiko
Y
Taura
Takashi
T
Ohba
Hidetaka
H
Katabuchi
D015067:17-Hydroxysteroid Dehydrogenases / Q000096:biosynthesis / Q000276:immunology / Q000378:metabolism*; D000328:Adult; D000906:Antibodies / Q000737:chemistry / Q000276:immunology; D000077216:Carcinoma, Ovarian Epithelial; D048708:Cell Growth Processes / Q000187:drug effects; D004847:Epithelial Cells / Q000201:enzymology / Q000378:metabolism; D004848:Epithelium / Q000201:enzymology / Q000378:metabolism; D004967:Estrogens / Q000096:biosynthesis / Q000378:metabolism; D005260:Female; D012739:Gonadal Steroid Hormones / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D007527:Isoenzymes; D008875:Middle Aged; D009375:Neoplasms, Glandular and Epithelial / Q000201:enzymology / Q000473:pathology; D010051:Ovarian Neoplasms / Q000201:enzymology / Q000473:pathology; D010053:Ovary / Q000201:enzymology* / Q000378:metabolism
D000906:Antibodies; D004967:Estrogens; D012739:Gonadal Steroid Hormones; D007527:Isoenzymes; D015067:17-Hydroxysteroid Dehydrogenases; C044256:3 (or 17)-beta-hydroxysteroid dehydrogenase
Cancer Res. 1982 Aug;42(8 Suppl):3365s-3368s
7083201
Endocr Rev. 1991 Feb;12(1):14-26
1851084
Curr Probl Cancer. 1992 Jan-Feb;16(1):1-57
1547635
J Steroid Biochem Mol Biol. 2002 Aug;81(4-5):343-51
12361724
J Histochem Cytochem. 1997 Mar;45(3):327-43
9071315
Mol Endocrinol. 2006 Feb;20(2):437-43
16166196
Adv Exp Med Biol. 2008;630:148-65
18637490
Endocr Rev. 2001 Apr;22(2):255-88
11294827
Hum Reprod Update. 2003 May-Jun;9(3):193-205
12861966
Gynecol Oncol. 2008 Mar;108(3):641-51
18221779
Panminerva Med. 2006 Mar;48(1):13-7
16633327
J Steroid Biochem. 1985 Jan;22(1):63-6
3974228
J Cell Biochem Suppl. 1995;23:208-18
8747398
Int J Gynecol Cancer. 2007 Jan-Feb;17(1):37-43
17291229
Int J Cancer. 1983 Oct 15;32(4):413-22
6311758
Int J Oncol. 2002 Sep;21(3):583-9
12168103
Lancet. 2007 May 19;369(9574):1703-10
17512855
Mol Cell Endocrinol. 2006 Mar 27;248(1-2):61-71
16414178
Mol Cell Endocrinol. 2004 Apr 15;218(1-2):7-20
15130507
J Steroid Biochem. 1980 Jan;13(1):89-94
7382486
J Mol Endocrinol. 1999 Aug;23(1):1-11
10431140
Carcinogenesis. 2000 Mar;21(3):427-33
10688862
Gynecol Oncol. 2006 Nov;103(2):623-30
16806441
Nihon Sanka Fujinka Gakkai Zasshi. 1990 Aug;42(8):812-22
2172418
Cancer. 1994 Apr 1;73(7):1859-64
8137211
Mol Hum Reprod. 2005 Sep;11(9):615-21
16219629
Am J Pathol. 1977 Jun;87(3):686-720
194486
J Natl Cancer Inst Monogr. 2000;(27):67-73
10963620
Biochem J. 2007 Mar 15;402(3):419-27
17067289
Mol Cell Endocrinol. 2007 Feb;265-266:71-6
17234335
Int Rev Cytol. 2005;242:1-54
15598466
Chem Biol Interact. 2009 Mar 16;178(1-3):228-33
19022235
Mod Pathol. 1996 Apr;9(4):386-91
8729977
Cancer. 1972 Jun;29(6):1653-64
5031251
Cancer Causes Control. 2008 Aug;19(6):605-13
18264784
J Mol Endocrinol. 2000 Aug;25(1):1-16
10915214
Gynecol Oncol. 2001 Jul;82(1):116-21
11426972
Mol Cell Endocrinol. 2006 Mar 27;248(1-2):47-55
16413960